Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 521-526

  Mårild, Staffan ^a   Jodal, Ulf ^a   Sandberg, Torsten ^b  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Ceftibuten; Children; Pyelonephritis; Treatment; Trimethoprim sulfamethoxazole; Urinary tract infection

Indexed keywords

CEFTIBUTEN; COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE URINARY TRACT INFECTION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SWEATING; THRUSH; TREATMENT DURATION; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 59949105794     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0996-6     Document Type: Article

References (22)

1. Jodal U (1994) Treatment trials on children with acute pyelonephritis. Pediatr Nephrol 8:278-279
2. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearny DH, Reynolds EA, Ruley J, Janovsky JÉ (1999) Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 104:79-86
3. Montini G, Toffolo A, Zucchetta P, Dall'Amico R, Gobber D, Calderan A, Maschio F, Pavanello L, Molinari PP, Scorrano D, Zanchetta S, Cassar W, Brisotto P, Corsini A, Sartori S, Da Dalt L, Murer L, Zacchello G (2007) Antibiotic treatment for pyelonephritis in children: Multicentre randomised controlled non-inferiority trial. Br Med J 335:386
4. Neuhaus TJ, Berger C, Buechner K, Parvex P, Bischoff G, Goetschel P, Husarik D, Willi U, Molinari L, Rudin C, Gervaix A, Hunziker U, Stocker S, Girardin E, Nadal D (2008) Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis. Eur J Pediatr 167:1037-1047
5. American Academy of Pediatrics (1999) Practice parameter: The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 103:843-852
6. Hodson EM, Willis NS, Craig JC (2007) Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (4):CD003772
7. Jones R (1993) Ceftibuten: A review or antimicrobial activity, spectrum and other microbiologic features. Pediatr Infect Dis J 12:S37-S44
8. Barr WH (1991) The pharmacokinetics of ceftibuten in humans. Diagn Microbiol Infect Dis 14:93-100
9. Olsson-Liljequist B, Larsson P, Walder M, Miörner H (1997) Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis 105:S13-23
10. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE (1992) Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 15[Suppl 1]:S216-227
11. Good P (2000) Permutation tests: A practical guide to resampling methods for testing hypotheses, 2nd edn. Springer, New York, pp 36-42
12. SWEDRES (2006) A report on Swedish antibiotic utilisation and resistance in human medicine. Available at: http://www.strama.org
13. Brown PD, Freeman A, Foxman B (2002) Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 34:1061-1066
14. Jodal U, Winberg J (1987) Management of children with unobstructed urinary tract infection. Pediatr Nephrol 1:647-656
15. Sandberg T, Englund G, Lincoln K, Nilsson LG (1990) Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 9:317-323
16. Cronberg S, Banke S, Bergman B, Boman H, Eilard T, Elbel E, Hugo-Persson M, Johansson E, Kuylenstierna N, Lanbeck P, Lindblom A, Paulsen O, Schönbeck C, Walder M, Wieslander P (2001) Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 33:339-343
17. Stamm WE, McKevitt M, Counts GW (1987) Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. Ann Intern Med 160:341-345
18. Tartaglione TA, Johnson CR, Brust P, Opheim K, Hooton TM, Stamm WE (1988) Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis. Antimicrob Agents Chemother 32:1640-1643
19. Winberg J, Herthelius-Elman M, Möllby R, Nord CE (1993) Pathogenesis of urinary tract infection - experimental studies of vaginal resistance to colonization. Pediatr Nephrol 7:509-514
20. Swedish Urinary Tract Infection Study Group (1995) Interpretations of the bacteriologic outcome of antibiotic treatment for uncomplicated cystitis: Impact of the definition of significant bacteriuria in a comparison of ritipenem acoxil with norfloxacin. Clin Infect Dis 20:507-513
21. Hansson S, Jodal U, Norén L, Bjure J (1989) Untreated bacteriuria in asymptomatic girls with renal scarring. Pediatrics 84:964-968
22. Kemper KJ, Avner ED (1992) The case against screening urinalyses for asymptomatic bacteriuria in children. Am J Dis Child 146:343-346